Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
99
100
Next >
Bristol Myers' Breyanzi Scores Second FDA Approval For Blood Cancers Therapy
March 15, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
March 15, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BGNE
NVS
RHHBY
FDA Approves Intuitive Surgical's Da Vinci 5 Surgical System, Analyst Outlines Sees Long-Term Growth Potential
March 15, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ISRG
FDA Conditionally Approves Madrigal Pharmaceuticals' Resmetirom As First Treatment For Fatty Liver Disease With Scarring
March 15, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MDGL
What's Going On With Cancer Focused-Geron Stock On Friday?
March 15, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
GERN
NANO Digital Rechargeable Hearing Aids: Oticon & Phonak Alternative Launched
March 12, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
MDGL Stock Alert: The Historic Reason Madrigal Is Up 19% Today
March 15, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
ISRG
MDGL
RIVN
RLX
Novo Nordisk Just Scored a Huge Win. And It's Not Related to Ozempic
March 15, 2024
Via
The Motley Fool
Exposures
Product Safety
Tickers
NVO
ISRG Stock Alert: The FDA Is Giving Intuitive Surgical a Big Boost
March 15, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
ERNA
ISRG
KOPN
RIVN
Origin Manufacturing Revolutionises Kitchenware with Microwave Safe Plastic Bowls
March 14, 2024
Via
AB Newswire
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
Intuitive Surgical Pops After Winning FDA Clearance For Next-Gen Robotic System
March 14, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
ISRG
FDA Approves Mirum's Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy
March 14, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MIRM
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System
March 14, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
BEAT
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Reports on Meeting with FDA to Review End of Phase 2 Study, Proposed Phase 3 Program
March 14, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CYBN
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
March 13, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
JNJ
LEGN
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces FY 2023 Results, Recent Operating Highlights
March 13, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
March 13, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CMPS
CYBN
MNMD
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Adds Korean Patent for Leading Drug Candidate to Growing International Patent Portfolio
March 13, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
GNPX
NATIONALLY RANKED ROSEN LAW FIRM Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 12, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
NATIONALLY RANKED ROSEN LAW FIRM Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 12, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
Why Geron Stock Is Falling Today
March 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GERN
FDA Casts Doubts On Geron's Blood Cancer Drug, But Analyst Sees High Probability For Imetelstat's Potential Approval For MDS Anemia Treatment
March 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GERN
IRHYTHM (IRTC) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies iRhythm Investors of a Class Action Lawsuit and Upcoming Deadline
March 12, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
IRTC
IRHYTHM (IRTC) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies iRhythm Investors of a Class Action Lawsuit and Upcoming Deadline
March 12, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
IRTC
This Nasal Spray Rapidly Reverses Effects Of Fentanyl Overdose And No, It's Not Naloxone
March 12, 2024
Via
Benzinga
Topics
Death
Exposures
Death
Product Safety
Tickers
INDV
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
March 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
SYRA
Jim Cramer Recalls Big Mistake Of His Early Investing Career: 'You're Trading, Not Investing'
March 12, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
March 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
SAVA
Sofwave Medical Pioneers Non-Invasive Treatment for Arm Reduction and Improved Skin Elasticity With Its Revolutionary SUPERB Technology
March 11, 2024
Via
Get News
Exposures
Product Safety
Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week
March 11, 2024
Via
Talk Markets
Exposures
Product Safety
Tickers
ATAI
CMPS
GHRS
IXHL
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.